Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.

Brand M, Adamik J, Wang H, Sember SE, Muzzio JL, Buffo MJ, Sander CA, Kirkwood JM, Ferris RL, Butterfield LH, Vujanovic L

Open source

DOI
10.1080/2162402x.2025.2595764
Published
2025 Dec 31
Container
Oncoimmunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/2162402x.2025.2595764,
  title = {Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.},
  author = {Brand M and Adamik J and Wang H and Sember SE and Muzzio JL and Buffo MJ and Sander CA and Kirkwood JM and Ferris RL and Butterfield LH and Vujanovic L},
  year = {2025},
  journal = {Oncoimmunology},
  doi = {10.1080/2162402x.2025.2595764},
  url = {https://doi.org/10.1080/2162402x.2025.2595764}
}

RIS

TY  - JOUR
TI  - Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.
AU  - Brand M
AU  - Adamik J
AU  - Wang H
AU  - Sember SE
AU  - Muzzio JL
AU  - Buffo MJ
AU  - Sander CA
AU  - Kirkwood JM
AU  - Ferris RL
AU  - Butterfield LH
AU  - Vujanovic L
PY  - 2025
JO  - Oncoimmunology
DO  - 10.1080/2162402x.2025.2595764
UR  - https://doi.org/10.1080/2162402x.2025.2595764
ER  - 

APA

M, B., J, A., H, W., SE, S., JL, M., MJ, B., CA, S., JM, K., RL, F., LH, B., & L, V. (2025). Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.. Oncoimmunology. https://doi.org/10.1080/2162402x.2025.2595764

Source records